Latest Earnings Results: Q2 '26
Estimated EPS
-$0.76
Reported EPS
-$0.90
Surprise
-18.14%
Estimated Rev
$314.23M
Reported Rev
$334.98M
Surprise
+6.6%
$GH Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.90 down -12.50% YoY • Reported revenue of $334.98M up 44.33% YoY • Guardant Health now expects full year 2026 revenue in the range of $1.34 to $1.36 billion, representing growth of 36% to 38% compared to the prior range of $1.30 to $1.32 billion.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | -$0.75 | -- | -- | N/A |
Q2 '26 | -$0.76 | -$0.90 | -18.14% | MISSED |
Q1 '26 | -$0.81 | -$0.85 | -5.46% | MISSED |
Q4 '25 | -$0.77 | -$1.00 | -30.42% | MISSED |
Q3 '25 | -$0.79 | -$0.74 | 6.28% | BEAT |